RO.SW

Roche Holding AG [RO.SW] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

RO.SW Stock Summary

Top 10 Correlated ETFs

RO.SW

Top 10 Correlated Stocks

RO.SW

In the News

RO.SW Financial details

Company Rating
-
Market Cap
182.34B
Income
23.92B
Revenue
122B
Book val./share
-
Cash/share
-
Dividend
9.5
Dividend %
3.51%
Employees
103.61K
Optionable
No
Shortable
Yes
Earnings
25 Jul 2024
P/E
19.74
Forward P/E
-
PEG
2.15
P/S
3.21
P/B
8.21
P/C
-
P/FCF
15.17
Quick Ratio
0.71
Current Ratio
1.18
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
29.81
EPS next Y
-
EPS next Q
-
EPS this Y
-7.34%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-1.81%
Revenue last 5Y
-1.63%
Revenue Q/Q
-2.83%
EPS Q/Q
-38.75%
-
-
-
-
SMA20
-0.85%
SMA50
-13.83%
SMA100
3.38%
Inst Own
-
Inst Trans
-
ROA
13%
ROE
40%
ROC
0.34%
Gross Margin
73%
Oper. Margin
31%
Profit Margin
18%
Payout
69%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
229.4-318.0
52W High
-11.95%
52W Low
+22.27%
RSI
49.82
Rel Volume
4.53
Avg Volume
33.58K
Volume
152.29K
Perf Week
0.43%
Perf Month
5.26%
Perf Quarter
3.4%
Perf Half Y
4.48%
-
-
-
-
Beta
0.148
-
-
Volatility
1.96%, 6.31%
Prev Close
1.08%
Price
280
Change
0.94%

RO.SW Financial Performance

RO.SW Dividend History

RO.SW Frequently Asked Questions

What is Roche Holding AG stock symbol ?

Roche Holding AG is a CH stock and trading under the symbol RO.SW

What is Roche Holding AG stock quote today ?

Roche Holding AG stock price is $280 today.

Is Roche Holding AG stock public?

Yes, Roche Holding AG is a publicly traded company.

Something similar

Top by Market Cap
FB2A.DE
VFINX
BRK-A
APC.DE
AAPL
Top Correlated ETFs
HLTW.L
WHEA.L
XDWH.L
JPST.L
LYHLTW.SW
Top Correlated Stocks
ROG.SW
3LAZ.L
UKW.L
0QF8.L
VEI.OL
Similar Market Cap
SOBHA.NS
4118.T
6239.TW
003650.KS
017900.KS

Company Profile

Healthcare Drug Manufacturers - General
  • Volume Average 33.58K
  • Market Capitalization 182.34B
  • Employee 103.61K
  • CEO Dr. Thomas Schinecker
  • Headquarters Basel,CH
  • IPO Date 1995-08-03
  • Website https://www.roche.com

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. The company offers pharmaceutical products for treating oncology, neuroscience, infectious, immunology, cardiovascular and metabolism, ophthalmology, and respiratory, as well as anemia, cancer, dermatology, hemophilia, inflammatory and autoimmune, neurological, and transplantation. It also offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases. In addition, the company supplies diagnostic instruments and reagents. The company was founded in 1896 and is headquartered in Basel, Switzerland.